Lucid Diagnostics Inc. (LUCD) — Stock Score Summary

Lucid Diagnostics Inc. (LUCD) has a MoatMap StockRank of 15/100 based on Quality (11/100), Value (44/100), and Momentum (45/100) factor scores. The current signal is STRONG SELL. Lucid Diagnostics Inc., a US healthcare company (diagnostics), lacks a direct, unpriced macro tailwind from our identified themes to create an asymmetric opportunity. As a small-cap company in a competitive healthcare segment, it would need exceptional quality and growth prospects to overcome the 'STRONG_SELL' quantitative signal. Without detailed company-specific data to support a high-conviction case, it does not meet our fund's strict criteria.

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company dedicated to the early detection of esophageal precancer and cancer through its proprietary EsoGuard® Esophageal DNA Test and EsoCheck® device. The company’s competitive advantage lies in offering a minimally invasive, first-in-class solution that addresses a significant unmet medical need for timely intervention in esophageal adenocarcinoma.

Key Financial Metrics

Price$1.07
Market Cap$204M
P/E (Forward)-5.41
Price/Book-25.59
Return on Invested Capital-488.8%
Debt/Equity670.08
Gross Margin-31.4%
Operating Margin-964.5%
Revenue Growth51.7%
Free Cash Flow$-26M

Lucid Diagnostics Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Lucid Diagnostics Inc.’s (LUCD) StockRank?
MoatMap’s StockRank for Lucid Diagnostics Inc. (LUCD) is 15/100, with a Strong Sell signal. It is a composite of Quality (11), Value (44), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Lucid Diagnostics Inc. have an economic moat?
Lucid Diagnostics Inc. (LUCD) has a Quality factor score of 11/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lucid Diagnostics Inc. a buy, hold, or sell?
MoatMap’s current signal for Lucid Diagnostics Inc. (LUCD) is Strong Sell, based on a StockRank of 15/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Lucid Diagnostics Inc. in?
Lucid Diagnostics Inc. (LUCD) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksLUCD deep dive reportAI ChampionsHow we score stocksSense-check another stock